Search research articles
Contact Us
Filters
Showing results (81-90 of 178) with videos related to
Page
of 18
Sort By:
Neurology
|
March 18, 2014
MATILDE chemotherapy regimen for primary CNS lymphoma: results at a median follow-up of 12 years
Andrés J M Ferreri, Fabio Ciceri, Alba A Brandes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 2008
MGMT promoter methylation status can predict the incidence and outcome of pseudoprogression after concomitant radiochemotherapy in newly diagnosed glioblastoma patients
Alba A Brandes, Enrico Franceschi, Alicia Tosoni, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 8, 2003
The treatment of adults with medulloblastoma: a prospective study
Alba A Brandes, Mario Ermani, Pietro Amista, et al.
Anticancer Research
|
March 10, 2015
The effect of re-operation on survival in patients with recurrent glioblastoma
Enrico Franceschi, Marco Bartolotti, Alicia Tosoni, et al.
Journal of Clinical Pathology
|
August 29, 2015
Contribution of microRNA analysis to characterisation of pancreatic lesions: a review
Michela Visani, Giorgia Acquaviva, Sirio Fiorino, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 18, 2006
1p/19q loss within oligodendroglioma is predictive for response to first line temozolomide but not to salvage treatment
Mathilde C M Kouwenhoven, Johan M Kros, Pim J French, et al.
Oncotarget
|
September 15, 2017
Early tumour shrinkage as a survival predictor in patients with recurrent glioblastoma treated with bevacizumab in the AVAREG randomized phase II study
Alba A Brandes, Gaetano Finocchiaro, Vittorina Zagonel, et al.
Future Oncology (London, England)
|
May 22, 2020
Fighting cancer in coronavirus disease era: organization of work in medical oncology departments in Emilia Romagna region of Italy
Alba A Brandes, Andrea Ardizzoni, Fabrizio Artioli, et al.
Future Oncology (London, England)
|
May 10, 2018
Temozolomide rechallenge in recurrent glioblastoma: when is it useful?
Enrico Franceschi, Giuseppe Lamberti, Michela Visani, et al.
Histopathology
|
February 17, 2012
Prognostic value of Ki67 index in anaplastic oligodendroglial tumours--a translational study of the European Organization for Research and Treatment of Cancer Brain Tumor Group
Matthias Preusser, Romana Hoeftberger, Adelheid Woehrer, et al.
Page
of 18
Search research articles
Search
Showing results (81-90 of 178) with videos related to
Sort By:
Page
of 18
Neurology
|
March 18, 2014
MATILDE chemotherapy regimen for primary CNS lymphoma: results at a median follow-up of 12 years
Andrés J M Ferreri, Fabio Ciceri, Alba A Brandes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 2008
MGMT promoter methylation status can predict the incidence and outcome of pseudoprogression after concomitant radiochemotherapy in newly diagnosed glioblastoma patients
Alba A Brandes, Enrico Franceschi, Alicia Tosoni, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 8, 2003
The treatment of adults with medulloblastoma: a prospective study
Alba A Brandes, Mario Ermani, Pietro Amista, et al.
Anticancer Research
|
March 10, 2015
The effect of re-operation on survival in patients with recurrent glioblastoma
Enrico Franceschi, Marco Bartolotti, Alicia Tosoni, et al.
Journal of Clinical Pathology
|
August 29, 2015
Contribution of microRNA analysis to characterisation of pancreatic lesions: a review
Michela Visani, Giorgia Acquaviva, Sirio Fiorino, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 18, 2006
1p/19q loss within oligodendroglioma is predictive for response to first line temozolomide but not to salvage treatment
Mathilde C M Kouwenhoven, Johan M Kros, Pim J French, et al.
Oncotarget
|
September 15, 2017
Early tumour shrinkage as a survival predictor in patients with recurrent glioblastoma treated with bevacizumab in the AVAREG randomized phase II study
Alba A Brandes, Gaetano Finocchiaro, Vittorina Zagonel, et al.
Future Oncology (London, England)
|
May 22, 2020
Fighting cancer in coronavirus disease era: organization of work in medical oncology departments in Emilia Romagna region of Italy
Alba A Brandes, Andrea Ardizzoni, Fabrizio Artioli, et al.
Future Oncology (London, England)
|
May 10, 2018
Temozolomide rechallenge in recurrent glioblastoma: when is it useful?
Enrico Franceschi, Giuseppe Lamberti, Michela Visani, et al.
Histopathology
|
February 17, 2012
Prognostic value of Ki67 index in anaplastic oligodendroglial tumours--a translational study of the European Organization for Research and Treatment of Cancer Brain Tumor Group
Matthias Preusser, Romana Hoeftberger, Adelheid Woehrer, et al.
Page
of 18